Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent
Clinical trial NCT03984838 · COMPLETED
Trial details
- NCT number
- NCT03984838
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2019-08-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.